The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines
Abstract
Anti‐complement immunofluorescence (ACIF) was used to study the complementfixing antigens of human lymphoblastoid cell lines. These cell lines carry the Epstein‐Barr virus (EBV) genome although only producer cultures synthetize EBV‐specific antigens (virus capsid antigen, VCA and early antigen, EA) detectable by direct and indirect immunofluorescence, usually in less than 5% of the cells. The ACIF test revealed an antigen localized in the nucleus of the lymphoblastoid cells. In contrast to EA and VCA, this antigen was present in over 90% of the cells of both producer and non‐producer cultures. The antigen was shown to be specific for EBV by comparing the reactions of 52 sera in the ACIF test. Sera giving the nuclear reaction contained antibodies to VCA, EA or antigens detectable by complement fixation tests on cell extracts, but sera without EBV antibodies failed to give the reaction. Weak, equivocal or discordant reactions occurred with six sera with low titres in VCA, EA or complement fixation tests. Cell lines derived by transformation of human and primate lymphocytes by EBV gave the nuclear reaction. Control cells with no known association with EBV were non‐reactive. These included foetal lymphocytes transformed by phytohaemagglutinin, cell lines derived from breast cancer, glioma, normal glia, pleuritis maligna and myeloma, and two marmoset lymphoid lines carrying Herpesvirus saimiri (HVS). In preliminary experiments, the ACIF test was used as a tool to trace the EBV genome at the cellular level. Cells from two Burkitt lymphoma biopsies, one tested after biopsy and one after passaging in nude mice, contained an EBV‐specific antigen. Three clones of cells derived from hybrids of mouse somatic cells and a human lymphoblastoid cell line also contained such an antigen, but the number of reactive cells varied from clone to clone. A fourth clone was non‐reactive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunofluorescence in Cells Derived from Burkitt's Lymphoma
Henle, G., & Henle, W. (1966) · Journal of Bacteriology · doi:10.1128/jb.91.3.1248-1256.1966 · Cited by 1,439
HAUSEN, H. Z., SCHULTE-HOLTHAUSEN, H., KLEIN, G., HENLE, W., HENLE, G., CLIFFORD, P., & SANTESSON, L. (1970) · Nature · doi:10.1038/2281056a0 · Cited by 1,254
Self-citationSurface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.
Klein, E., Klein, G., Nadkarni, J. S., Nadkarni, J. J., Wigzell, H., & Clifford, P. (1968) · PubMed · Cited by 831
Self-citationA study of malignant tumours in Nigeria by short-term tissue culture
Pulvertaft, R. J. V. (1965) · Journal of Clinical Pathology · doi:10.1136/jcp.18.3.261 · Cited by 578
Pope, J. H., Horne, M. K., & Scott, W. M. (1968) · International Journal of Cancer · doi:10.1002/ijc.2910030619 · Cited by 472
Antibodies to Epstein-Barr Virus in Burkitt's Lymphoma and Control Groups 2
(1969) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/43.5.1147 · Cited by 415
Morphological and Virological Investigations on Cultured Burkitt Tumor Lymphoblasts (Strain Raji)2
(1966) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/37.4.547 · Cited by 386
Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies
Niederman, J. C. (1968) · JAMA · doi:10.1001/jama.203.3.205 · Cited by 372
Nilsson, K., Klein, G., Henle, W., & Henle, G. (1971) · International Journal of Cancer · doi:10.1002/ijc.2910080312 · Cited by 357
Self-citationPresence of EB Virus Nucleic Acid Homology in a “Virus-free” Line of Burkitt Tumour Cells
HAUSEN, H. Z., & SCHULTE-HOLTHAUSEN, H. (1970) · Nature · doi:10.1038/227245a0 · Cited by 312
Cited by
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
Lozzio, C., & Lozzio, B. (1975) · Blood · doi:10.1182/blood.v45.3.321.321 · Cited by 2,995
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
Morgan, D. A., Ruscetti, F. W., & Gallo, R. (1976) · Science · doi:10.1126/science.181845 · Cited by 2,493
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
Sundström, C., & Nilsson, K. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170504 · Cited by 2,407
Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)
Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., & Tada, K. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260208 · Cited by 2,254
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture
COLLINS, S. J., GALLO, R. C., & GALLAGHER, R. E. (1977) · Nature · doi:10.1038/270347a0 · Cited by 2,094
Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative Disorders
Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M., Halligan, G., Biberfeld, P., Wong-Staal, F., Kramarsky, B., et al. (1986) · Science · doi:10.1126/science.2876520 · Cited by 1,428
Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine
Tan, E. M. (1982) · Advances in Immunology · doi:10.1016/s0065-2776(08)60836-6 · Cited by 965
Gallagher, R., Collins, S., Trujillo, J., McCredie, K., Ahearn, M., Tsai, S., Metzgar, R., Aulakh, G., Ting, R., Ruscetti, F., et al. (1979) · Blood · doi:10.1182/blood.v54.3.713.713 · Cited by 925
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995) · Nature · doi:10.1038/375685a0 · Cited by 823
Self-citationGreenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V., & Freese, U. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132502 · Cited by 805
zur Hausen, H. (1991) · Science · doi:10.1126/science.1659743 · Cited by 784
Establishment of an immature mast cell line from a patient with mast cell leukemia
Butterfield, J. H., Weiler, D., Dewald, G., & Gleich, G. J. (1988) · Leukemia Research · doi:10.1016/0145-2126(88)90050-1 · Cited by 737
Autoantibody to centromere (kinetochore) in scleroderma sera.
Moroi, Y., Peebles, C., Fritzler, M. J., Steigerwald, J., & Tan, E. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1627 · Cited by 729
Schneider, U., Schwenk, H., & Bornkamm, G. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190505 · Cited by 700
Efficient Persistence of Extrachromosomal KSHV DNA Mediated by Latency-Associated Nuclear Antigen
Ballestas, M. E., Chatis, P. A., & Kaye, K. M. (1999) · Science · doi:10.1126/science.284.5414.641 · Cited by 694
The role of gene dosage and genetic transpositions in carcinogenesis
Klein, G. (1981) · Nature · doi:10.1038/294313a0 · Cited by 659
Self-citationde-Thé, G., Geser, A., Day, N. E., Tukei, P. M., Williams, E. H., Beri, D. P., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, P., et al. (1978) · Nature · doi:10.1038/274756a0 · Cited by 613
CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS
Bennett, M., Farrer-Brown, G., Henry, K., Jelliffe, A. M., Gerard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A. G., & Van Unnik, J. A. M. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91786-3 · Cited by 555
Persisting Illness and Fatigue in Adults with Evidence of Epstein-Barr Virus Infection
STRAUS, S. E., TOSATO, G., ARMSTRONG, G., LAWLEY, T., PREBLE, O. T., HENLE, W., DAVEY, R., PEARSON, G., EPSTEIN, J., BRUS, I., et al. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-1-7 · Cited by 541
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
Lennette, E. T., Blackbourn, D. J., & Levy, J. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03240-0 · Cited by 533
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E., & Rousset, F. (1991) · Science · doi:10.1126/science.1702555 · Cited by 533
Rawlins, D. R., Milman, G., Hayward, S. D., & Hayward, G. S. (1985) · Cell · doi:10.1016/0092-8674(85)90282-x · Cited by 506
Congenital Cytomegalovirus Infection: Occurrence in an Immune Population
Stagno, S., Reynolds, D. W., Huang, E.-S., Thames, S. D., Smith, R. J., & Alford, C. A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706022962203 · Cited by 490
The Pathogenesis of Burkitt's Lymphoma
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 466
Hodgkin's Disease and Epstein-Barr Virus
Mueller, N., Evans, A., Harris, N. L., Comstock, G. W., Jellum, E., Magnus, K., Orentreich, N., Polk, B. F., & Vogelman, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201103 · Cited by 445
Imai, S., Koizumi, S., Sugiura, M., Tokunaga, M., Uemura, Y., Yamamoto, N., Tanaka, S., Sato, E., & Osato, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9131 · Cited by 445
Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas
Gazdar, A., Carney, D., Bunn, P., Russell, E., Jaffe, E., Schechter, G., & Guccion, J. (1980) · Blood · doi:10.1182/blood.v55.3.409.409 · Cited by 442
Reisman, D., Yates, J., & Sugden, B. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.1822-1832.1985 · Cited by 186
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia
Klein, E., Vánky, F., Ben‐Bassat, H., Neumann, H., Ralph, P., Zeuthen, J., & Polliack, A. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910180405 · Cited by 423
Herpesvirus Infections in the Acquired Immune Deficiency Syndrome
Quinnan, G. V. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350010038020 · Cited by 398
EB virus-induced B lymphocyte cell lines producing specific antibody
STEINITZ, M., KLEIN, G., KOSKIMIES, S., & MAKEL, O. (1977) · Nature · doi:10.1038/269420a0 · Cited by 392
Self-citationBuchwald, D., Cheney, P. R., Peterson, D. L., Henry, B., Wormsley, S. B., Geiger, A., Ablashi, D. V., Salahuddin, S. Z., Saxinger, C., Biddle, R., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-2-103 · Cited by 384
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
Dambaugh, T., Hennessy, K., Chamnankit, L., & Kieff, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7632 · Cited by 383
Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.
Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Müller-Lantzsch, N., & Stein, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4766 · Cited by 383
Reisman, D., & Sugden, B. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.11.3838 · Cited by 366
Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J., & Sergeant, A. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04635.x · Cited by 362
A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals
Yao, Q. Y., Rickinson, A. B., & Epstein, M. A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350107 · Cited by 338
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions
De Paschale, M. (2012) · World Journal of Virology · doi:10.5501/wjv.v1.i1.31 · Cited by 333
Horizontal Transfer of DNA by the Uptake of Apoptotic Bodies
Holmgren, L., Szeles, A., Rajnavölgyi, E., Folkman, J., Klein, G., Ernberg, I., & Falk, K. I. (1999) · Blood · doi:10.1182/blood.v93.11.3956 · Cited by 333
Self-citationKlein, G., Lindahl, T., Jondal, M., Leibold, W., Menézes, J., Nilsson, K., & Sundström, C. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.8.3283 · Cited by 331
Self-citationEvidence for a multistep pathogenesis of chronic myelogenous leukemia
Fialkow, P., Martin, P., Najfeld, V, Penfold, G., Jacobson, R., & Hansen, J. (1981) · Blood · doi:10.1182/blood.v58.1.158.158 · Cited by 326
Salahuddin, S. Z., Markhamt, P. D., Wong-staal, F., Franchini, G., Kalyanaraman, V. S., & Gallo, R. C. (1983) · Virology · doi:10.1016/0042-6822(83)90395-1 · Cited by 324
Ogura, M., Morishima, Y., Ohno, R., Kato, Y., Hirabayashi, N., Nagura, H., & Saito, H. (1985) · Blood · doi:10.1182/blood.v66.6.1384.1384 · Cited by 315
Fennewald, S., van Santen, V, & Kieff, E. (1984) · Journal of Virology · doi:10.1128/jvi.51.2.411-419.1984 · Cited by 302
Poiesz, B. J., Ruscetti, F. W., Mier, J. W., Woods, A. M., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6815 · Cited by 286
The curious case of the tumour virus: 50 years of Burkitt's lymphoma
Thorley-Lawson, D. A., & Allday, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro2015 · Cited by 282
Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T., et al. (1988) · Nature · doi:10.1038/333455a0 · Cited by 281
Lupton, S., & Levine, A. J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2533 · Cited by 274
Primary Epstein–Barr-Virus Infections in Acute Neurologic Diseases
Grose, C., Henle, W., Henle, G., & Feorino, P. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502202920804 · Cited by 261
Nagata, K., Ohtani, K., Nakamura, M., & Sugamura, K. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3220-3226.1989 · Cited by 239
Infectious transmission of human T‐cell leukemia virus to rabbits
Miyoshi, I., Yoshimoto, S., Kubonishi, I., Fujishita, M., Ohtsuki, Y., Yamashita, M., Yamato, K., Hirose, S., Taguchi, H., Niiya, K., et al. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350113 · Cited by 72
Metadata
- Authors
- Reedman, B. M., & Klein, G.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1973-05-15
- Volume
- 11
- Issue
- 3
- Pages
- 499-520
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1970748912
- Cited by
- 1,668
- References
- 14
- FWCI
- 52.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.